![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Ovarian Neoplasms |
|
Free Subscription
1 BMC Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
Homologous recombination deficiency in newly diagnosed advanced ovarian cancer
across nine Middle East countries: prevalence, real-world testing pathways, and
treatment implications.
BMC Cancer. 2026 Feb 4. doi: 10.1186/s12885-025-15537.
PubMed
Neutrophil Extracellular Traps Enhance Platinum Resistance in Ovarian Cancer via
SHP-1 Activation.
Cancer Lett. 2026 Jan 29:218288. doi: 10.1016/j.canlet.2026.218288.
PubMed
Abstract available
Understanding patient priorities: Sexual health and hereditary ovarian cancer
syndromes.
Gynecol Oncol. 2026;205:113-119.
PubMed
Abstract available
Endometrioma and Mature Cystic Teratoma as Collision Tumors of the Ovary: A Case
Series and Literature Review.
Int J Gynecol Pathol. 2026;45:142-151.
PubMed
Abstract available
Sex Cord-like Endometrioid Carcinoma Arising From Broad Ligament, a Challenging
Diagnosis: Report of 2 Cases.
Int J Gynecol Pathol. 2026;45:175-180.
PubMed
Abstract available
EML4::NTRK3 Rearranged Ovarian Neoplasm: Case Report and Literature Review.
Int J Gynecol Pathol. 2026;45:170-174.
PubMed
Abstract available
Molecular Subtype and Mutational Profile of Endometrial Atypical
Hyperplasia/Endometrioid Intraepithelial Neoplasia.
Int J Gynecol Pathol. 2026;45:120-128.
PubMed
Abstract available
Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress
and cell death in ovarian cancer.
Oncogene. 2026 Feb 6. doi: 10.1038/s41388-026-03689.
PubMed
Abstract available
Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive
and cisplatin-tolerant ovarian cancer cells.
PLoS One. 2026;21:e0342326.
PubMed
Abstract available
WNK2 may promote ovarian cancer progression by upregulating POU5F1B.
PLoS One. 2026;21:e0332003.
PubMed
Abstract available
Thank you for your interest in scientific medicine.